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When  immunized with  a  conjugate of keyhole  limpet hemocyanln  (KLH)  1 with p- 
azophenylarsonate (Ar) groups all A/J mice respond with the production of anti-hapten 
antibodies, a portion of which share a cross-reactive idiotype (CRI) (1). The percentage of 
anti-Ar antibody molecules in an individual mouse which boars the CRI generally varies 
between 20-70%. Since this idiotype has not been found in a large number of other strains 
immunized with the same antigen, it can serve as a genetic marker for the variable (V) 
regions of anti-Ar antibodies (2, 3). 
If, before immunization, a neonatal or adult A/J mouse is first challenged with rabbit 
anti-ldiotypic (anti-id) antibodies directed to the CRI, the idlotype almost always fails to 
appear upon subsequent immunization of the recipient mouse (4, 5). Such suppression of 
idiotype in vivo has been confirmed in other systems (e.g., references 6-8).  Despite the 
suppression of CRI, the immunized mice produce normal amounts of anti-Ar antibodies 
when challenged with KLH-Ar (5). These antibodies can, in turn, be used to elicit anti-id 
antibodies in rabbits (9). In contrast to the anti-Ar antibodies with CRI, the idiotypes 
arising in  suppressed,  hyperimmunized mice occur at very low frequency,  or are not 
detectable, in other immunized A/J mice, either suppressed or nonsuppressed (9, 10). For 
convenience,  we  will  refer  to  the  idiotypes  of the  anti-Ar  antibodies  of suppressed, 
immunized mice as "private" idiotypes. Since the radioimmunoassays used for detection 
of idlotypes are sensitive, minute concentrations of private idiotypes would be detected if 
present in the anti-Ar antibodies of other mice. 
These results have obvious implications with respect to the degree of hetero- 
geneity of the anti-Ar antibodies of the A/J strain.  However, a technical limita- 
tion becomes apparent in the interpretation of the data. It could be argued that a 
private  idiotype  is  actually  a  collection  of  idiotypes,  all  recognized  by  the 
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autologous rabbit antiserum.  Another immunized mouse might produce  some, 
but  not  all  of these  idiotypes;  only  partial  inhibition  of the  binding  of the 
autologous, labeled ligand would then be observed in the radioimmunoassay. To 
circumvent this possibility,  we have extended these experiments by subjecting 
purified  anti-Ar  antibodies  of three  randomly  selected,  hyperimmune  sup- 
pressed  mice,  bearing  private  idiotypes,  to isoelectric  focusing on  polyacryl- 
amide gels; four individual labeled peaks isolated from the gels were then used 
as  ligands  in radioimmunoassays  designed  to detect the presence  of private 
idiotypes  in the  anti-Ar  antibodies  of other A/J  mice.  The  antibodies in the 
peaks  selected  refocused  with  the  same  isoelectric  pH  (pI)  values;  another 
criterion used for selection was the reactivity of at least 90% of the radiolabeled 
protein in the peak with its anti-id antibodies. 
Data concerning the occurrence of such private idiotypes in other mice are 
presented here and are discussed in terms of the degree of diversity of anti-Ar 
antibodies in A/J mice and of possible mechanisms that might account for the 
diversity. 
Materials and Methods 
Experimental Animals.  Male A/J or BALB/c mice were obtained from The Jackson Labora- 
tory, Bar Harbor, Maine. A/J mice used for suppression of the cross-reactive idiotype were 6-wk 
old.  Mice  used  for the  preparation  of anti-Ar antibodies  were  8-12  wk  of age  at  the  start  of 
immunization 
Induction  of Antibodies  zn Ascztic Flmds.  This was done by the method of Tung et al.  (11). 
Essentially, it consists of repeated injection of a 9:1 emulsion of complete Freund's adjuvant (CFA) 
and antigen solution (KLH-Ar,  0.5 rag). The schedule of immunization and the method used for 
tapping of ascites have been described previously (11). 
Suppression of the Cross-Reactzve  Idiotype  and Induction of Ant~-Ar Antibodies ~n Suppressed 
Mice  The reagent used for suppression of the CRI, associated with the anti-Ar antibodies of A/J 
mice,  was  rabbit  anti-id  antiserum,  prepared  and  absorbed  as  described  below.  Two  0.5-ml 
injections were given intraperitoneally, 3 days apart  The idiotype-binding capacity of the antisera 
used for suppression was  approximately 60  /~g/ml.  This quantity of anti-id antibody, which is 
considerably higher than that used prewously, was found to suppress the CRI below the limits of 
detectability m  nearly all subsequently immunized mice. To reduce anti-Ar antibodies m  ascitic 
fluids of suppressed mice, essentially the same schedule of immunization was employed as that 
used for nonsuppressed animals (11); immunization was begun 2 wk after the inoculation of antl-id 
antiserum. 
Preparatmn  of Antl-zd Antibodies.  Anti-id antibodies against the CRI  characteristic of the 
anti-Ar antibodies of A/J mice were  prepared by a  method that chffered from that previously 
described (1), in that specifically purified anti-Ar antibodies, prepared from a large pool of ascitic 
fluids, rather than a  dissolved precipitate of the antibodies with a rabbit IgG-Ar conjugate, were 
used as  the lmmunogen.  Each  inoculation of the  rabbit utilized  1-1.5  mg of purified  anti-Ar 
antibody in a  1:1 emulsion of CFA and antigen solution. 3 ml were inJected in several subcuta- 
neous and intramuscular sites  A total of four injections were given, with 2-wk intervals between 
injections. Starting 2 wk after the last inoculation, the rabbits were bled weekly for 4 wk. Rabbit 
antisera were absorbed with a crude globulin fraction obtained from A/J ascitic fluid, induced with 
CFA alone. The anti-id antiserum obtained by this method was about 10 times stronger, in terms 
of idiotype-binding capacity per umt volume,  than antisera obtained by the method described 
earlier  (1).  Tests  for  anti-id  specificity  were  carried  out  by  radioimmunoassay  as  described 
previously (1, 4): they include inhibition by small amounts ofidiotype; the failure of large amounts 
of normal A/J serum, of anti-Ar antibodies from immunologically suppressed A/J mice which have 
high  titers  of anti-Ar antibodies,  or  anti-KLH-Ar  antibodies of BALB/c  mice,  to  inhibit the 
binding of the radioactive ligand (the immunogen) to the absorbed anti-id antibodies (10 ng of ~2sI- 
labeled  ligand  was  used  in  each  test);  and  the  inability  of the  absorbed  antl-ld  antibody to 
precipitate 125I-labeled  normal A/J IgG by the indirect (antl-giobulin) method. 542  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
Preparation of Ant~-ld Ant~sera  against Ant~-Ar Antibodies Arising in Immunolog~cally Sup- 
pressed A/J M~ce  As reported previously (5),  mine that  are  suppressed with  respect to  the 
appearance of the CRI produce normal amounts of the anti-Ar antlbodms when immunized by the 
conventional method with KLH-Ar. Anti-id antibodies can in turn be prepared against these anti- 
Ar antibodies (9)  The immunogen used to prepare such anti-id antibodies was, first, a dissolved 
precipitate (pH 3.5) of the anti-Ar antibodies with a rabbit IgG-Ar conjugate, emulsified in CFA. 
After two injections the rabbits were boosted with specifically purified anti-Ar antibodies prepared 
from the ascitic fired of  the same suppressed mouse  The latter inoculations resulted in substant:al 
increases m antl-id titers  The rabbit antibodms were absorbed in the usual manner and tested for 
ldiotyplc specificity by the radloimmunoassay  To mammize sensitivity, only 1.5-2 ng of labeled 
hgand  was used  Assays for the  presence of the  corresponding idiotype  m  the  sera  of other 
lmmumzed or nonlmmunlzed mice were carried out by measurement of the capacity to inhibit the 
binding of the radiolabeled ligand. In all cases (see Results) the unlabeled autologous antibody 
was a potent inhibitor of binding. 
Rad~o~mmunoassay  for Total Ant~-Ar Antibody  This method is based on that described by 
Khnman and his associates (personal communication). M:crotiter plates (model 220-24; Cooke 
Laboratory Products Div , Dynatech Laboratories Inc , Alexandria, Va.) were used. In&vldual 
wells were filled with a solution of bovine serum albumin (BSA)-Ar at a concentration of 1 mg/ml 
After standing overnight at room temperature, the wells were thoroughly washed, and then filled 
with a 2% solution of horse serum m borate-buffered saline, pH 8. On the following day, the plates 
were washed four times with the buffer, and 20  ~l of a  1'10 dilution of normal A/J serum was 
added. The test for antl-Ar antibodies was then carrmd out by adding 50  ~l of an appropriate 
dilution of serum to each well  After incubating at room temperature for 3 h, wells were washed 
four times with buffer. Then, 0.1 ml of specifically purified 12SI-labeled rabbit anti-mouse IgG was 
added to each well, in a  g:ven set of experiments, either 0 25 or 1 ~g of the labeled reagent was 
used  In each experiment a standard curve was obtained with A/J anti-Ar antiserum containing 
known  amounts  of anti-Ar  antibodies,  as  determined by  precipitm analysis  After standing 
overnight at 4°C, the plates were thoroughly washed with cold tap water, individual wells were cut 
out,  and  radioactivity was determined with  a  gamma  scmtillatmn counter  Control samples, 
lacking antl-Ar antibodies, were also run, and the small values obtained were subtracted from 
experimental data. Specificity was shown in each serms of tests by demonstrating the capacity of 
the hapten, p-arsanilate, to inhibit the binding of anti-Ar antibodies to the well.  Background 
values corresponded to the binding of approximately 2-5 ng of antl-Ar antibody  The assay m 
general was useful within a range of 3-40 ng of antl-Ar antibody  The average deviation from the 
mean of duplicate samples was less than 8%. 
Isoelectr~c Focusing  Isoelectnc focusing of specifically pur:fied antl-Ar antibodies was carried 
out m cylindrical, 5 ×  115 mm, 5% polyacrylamide gels; the solvent was 3 5 M demmzed urea and 
the final concentration of Amphohne (LKB  Instruments, Inc.,  Rockwlle,  Md.) was 2%  After 
focusing, the gels were either stained with Coomassle Blue  dye or subdivided with a  Savant 
Autogel Divider (Savant Instruments, Inc., Hickswlle, N  Y.)  using degassed 0 15  M NaCl  as 
eluant  Each gel yielded approximately 150 fractions of  five drops each. Details of  the method were 
reported previously (12).  The pH was determined on every fourth fraction by adding 0.5  ml of 
degassed saline solution and allowing particles to sediment before the measurement. To minimize 
denaturatmn, 0 6 ml of a solutmn containing 1% BSA in borate-buffered saline was added to each 
of the other fractmns. The overall recovery of extracted protein, as estimated from radioactlwty 
measurements, was over 60%. (It was found that the buffer was necessary for efficient extraction ) 
All samples applied to the gels were labeled with ~2sI to permit quantltation of the protein  When 
small amounts of labeled samples were used, normal mouse IgG was added as carrier immediately 
after the neutralizatmn of chloramme-T m  the lodmation procedure. 
Identzfication of the Subclass of  Ant~-Ar Antibodies.  Radiolmmunoassays were used to quantl- 
tate the subclass of certain mouse antibody fractions. For these tests ~2~I-labeled mouse antibodies 
were used. Subclass-specific  rabb:t ant:sera were obtained from Litton Bionetlcs, Kensington, Md 
An excess of rabbit antiserum was added to 1 5 ng of radiolabeled test sample, and an addltmnal 2 
~l of normal rabbit serum was added as carrmr  This was followed by an excess of goat anti-rabbit 
Fc that had been adsorbed with a  crude globulin fraction of mouse serum.  The percentage of 
radioactivity precipitated was then determined  The specificity of these tests was shown by using 
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Specifically Purified Rabbit Anti-Mouse IgG.  A/J IgG was conjugated to Sepharose-4B using a 
ratio of 2 mg of protein/m] of packed  gel. A portion was mixed wzth  excess rabbit  antiserum 
directed to mouse IgG (1 h at 37°C; overnight at 4°C). The mixture was packed into a column and 
washed extensively with borate-buffered saline, pH 8. The antibody was eluted with 2 M KSCN 
and immediately dialyzed and concentrated.  Estimated yields were 30-40% and  approximately 
75% of the protein was precipitable by mouse IgG. 
Other Methods.  We have previously described procedures for the preparation and purification 
ofanti-Ar antibodies, the preparation and absorptzon  of rabbit antz-id antzbodms,  radioimmunoas- 
say for the CRI of A/J antz-Ar antibodies  (1), preparation  of IgG from ascitic fluids (11), and 
conjugatzon  of proteins to Sepharose-4B (Pharmacza Free Chemicals, Inc. Piscataway, N. J.) (1, 
13). Radioiodination was carried out by the use ofchloramme-T (14). The radloimmunoassay was a 
double-antibody procedure, using goat anti-rabbzt Fc to precipitate complexes of labeled idiotype 
and  rabbit  antz-id  antibodies.  The synthesis  of (p-azobenzenearsomc acid)-N-acetyl-L-tyrosine 
(PABT) has been previously described (15). 
Results 
The  purpose  of these  experiments  was  to  study the  idiotypic properties  of 
homogeneous subfractions of anti-Ar  antibodies arising in A/J mice that  had 
been  suppressed  with  respect  to  the  CRI  normally  present  in  the  anti-Ar 
antibodies of the strain.  The results presented in Figs. 1-3 show the isoelectric- 
focusing patterns  of specifically purified,  125I-labeled  anti-Ar  antibodies of hy- 
perimmune  suppressed  mice,  designated  HIS-7,  HIS-13,  and  HIS-5,  respec- 
tively. The arrows in the figures indicate the peaks that were used in radioim- 
munoassays to detect the possible presence of private idiotypes in the antisera of 
other immunized A/J mice; in the case of HIS-7 the ligand  was obtained in a 
separate run, using a more highly labeled protein. The pattern was very similar 
to that shown in Fig.  1. 
That the heterogeneity with respect to pI values was not due to an artifact of 
the procedure was ascertained by refocusing protein in some of the peaks. The 
results obtained for two peaks present in the HIS-5 pattern are shown in Fig. 4. 
The peaks with pI values of 6.3 and 6.9 were mixed and refocused. To further 
facilitate identification, three times as much of the former material was used in 
the mixture.  The pI values of the refocused peaks agree within 0.0 and 0.1 pH 
unit with those of the originally extracted materials.  The data also show that 
the protein present in each peak of the heterogeneous mixture refocuses as a 
single peak (Figs.  3 and 4). Similar results were obtained with the major peak 
(pI 6.72)  of the anti-Ar  antibodies  of mouse HIS-7.  Upon refocusing,  a  single 
peak was obtained with a pI value of 6.75. 
Another  set  of control  experiments  was  carried  out  to  ascertain  whether 
iodination  causes  a  shift  in  the  pI  value.  The  number  of atoms  of  iodine 
incorporated per molecule of protein was less than 0.1 in each case.  It seemed 
possible that the presence of an atom of iodine might cause a  shift in pI. If this 
occurred,  then  the  concentration  of anti-Ar  antibodies  would not correspond 
precisely with levels of 125I shown in Figs.  1-3. This question was pursued with 
each of the preparations represented in those figures. The procedure consisted of 
adding  a  250-  to 600-fold excess of unlabeled  specifically purified  antibody to 
each labeled preparation.  Approximately 100/zg of the mixture was applied to 
the polyacrylamide gel and subjected to isoelectric focusing.  Two assays were 
carried out on each of approximately 150 fractions isolated from each run.  One 
was measurement of radioactivity; the other was determination of concentration 544  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
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FIG.  1.  Isoelectrm-focusing  pattern of specifically  purified antl-Ar antibodies of mouse 
HIS-7; fractions were obtained with the Autogel Divider. The sample was prepared by 
mixing the ~25I-labeled  antibody with a 600-fold excess of the same, unlabeled preparation. 
100/~g was applied to the gel  Each fraction was assayed for counts per minute (solid line). 
A 10 /~1 aliquot of each fraction was assayed for content of anti-Ar antibody (dotted hne) 
The arrow designates the pI value of the peak used as ligand for inhibition studies. Th~s 
hgand was obtained in a separate run with highly labeled protein. 
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FIG. 2.  Isoelectrm-focusing pattern of ~25I-labeled  specifically purified antl-Ar antibody of 
mouse HIS-13  The arrow designates the peak used in the radloimmunoassay  for ldiotype 
content. Approximately 20  /~g of labeled antibody and 80  /Lg of unlabeled A/J IgG (as 
carrier) were applied to the gel. 
of  anti-Ar antibodies by  the  assay  using  microtiter  plates,  described  under 
Materials and Methods.  A  typical run is shown in Fig.  1.  The correspondence 
between the curves obtained by the two procedures was very close and the peaks 
of anti-Ar antibody activity corresponded within experimental error with the 200 
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FIG.  3.  Isoelectrm-focusmg  pattern  of ~25I-labeled  specifically purified  anti-At antibodies 
of mouse  HIS-5  The arrows designate  the peaks  used in radloimmunoassays  for idiotype 
content.  Approximately  20  /~g  of labeled  antibody  and  80  pg  of unlabeled  A/J  IgG  (as 
carrier) were applied to the gel 
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FIG  4  Refocusing of the peaks with pI 6.3 and 6.9 from mouse HIS-5 (see Fig  3). The ratio 
of amounts of protein applied with pI 6.3 and 6,9 was 3:1. 
peaks  of radioactivity.  Any  shift  in  pI  due  to  iodination  is,  therefore,  not 
significant.  In nearly all of the peaks the ratio of counts per minute to anti-At 
activity was similar.  In a few peaks of proteins HIS-5 and HIS-13 the ratio was 
considerably higher than that observed in nearly all other peaks.  This may be 
due to very  low affinity  of the  anti-Ar  antibodies  in those  peaks,  preventing 
quantitative measurement of antibody content, or to a small degree of contami- 
nation by labeled protein lacking antibody activity.  In all cases,  however,  the 546  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
peaks of radioactivity and anti-Ar activity coincided. The presence of multiple 
bands  in each  preparation  was confirmed by using  unlabeled  antibodies  and 
staining with Coomassie Blue (without extraction). 
Investigation  of Subpopulations  from Antibodies  of Suppressed,  Hyperim- 
mune Mice.  The purpose of this work was to study homogeneous subpopula- 
tions  bearing  a  single  idiotype.  Those  peaks  chosen  for  further  study  are 
indicated by the arrows in Figs.  1-3. In addition to the uniformity with respect 
to  pI,  further  evidence  for  homogeneity  was  the  fact  that  over  90%  of the 
radioactivity  in  each  of the  four  designated  peaks  could  be  precipitated  by 
autologous anti-id antiserum. 
Quantitative tests for IgG subclasses were carried out on the labeled individ- 
ual peaks by the radioimmunoassay  described under  Materials  and  Methods; 
83-90% of the four proteins were IgG1; the remainder of the four proteins radio- 
activity was precipitable by antibodies to IgG2a and IgG2b. The totals for the 
three precipitations ranged from 96 to 102%. Radioimmunoassays for IgA or IgM 
were not carried  out but the  unfocused,  purified  antibodies all failed to form 
precipitin lines with anti-IgA or anti-IgM in the Ouchterlony test. This was as 
expected  since  the  purification  procedure  includes  passage  through  DEAE- 
cellulose in 0.04 M phosphate buffer, pH 8. 
Effects of  Haptens on the Binding of  Anti-id Antibodies to Ligands Isolated by 
Isoelectric Focusing.  These results are shown in Table I. In all instances, the 
hapten,  PABT, was a  potent inhibitor of binding.  This compound, that resem- 
bles a substituted tyrosyl side chain in the immunogen, has an average binding 
affinity for anti-Ar antibodies of nonsuppressed A/J mice of approximately 5 x 
105 to 1 x  106 M -1 (15); p-arsanilate,  which is smaller and would also be expected 
to have a lower binding affinity since it resembles the immunogen less closely, 
was somewhat less potent as an inhibitor, p-Aminobenzoate had no significant 
inhibitory effect on binding. 
Individuality of Private Idiotypes  in Antibodies  Isolated  by Isoelectric Focus- 
ing.  Tables II-V present data relating to the presence of'~private" idiotypes in 
anti-Ar antisera of a large number of mice. The four radioactive ligands used are 
the antibodies in the individual peaks indicated by the arrows in Figs. 1-3. Two 
of the ligands are from protein HIS-5 (peaks with pI 6.3 and 6.9); the other two 
are individual peaks obtained by isoelectric focusing of proteins HIS-7 and HIS- 
13. The idiotypes under investigation were shown by cross-inhibition studies to 
be unrelated, using specifically purified, unfocused anti-Ar antibodies as inhibi- 
tors. The weights of proteins HIS-5, HIS-7, and HIS-13 tested as inhibitors were 
125, 150, and 80/~g, respectively. 
Inhibitors tested in the various systems (Tables II-V) were ascitic fluids from 
A/J mice, or sera of BALB/c mice, immunized with KLH-Ar. The total anti-Ar 
antibody content was determined by the radioimmunoassay  (using Microtiter 
plates) described under Materials and Methods. 
In  the  radioimmunoassay  for  private  idiotypes,  25  /~l  of each  sample  was 
tested in duplicate  as the inhibitor.  There  was wide variation  in the  anti-Ar 
antibody concentration of the samples tested (0.4-8 mg/ml). As indicated in the 
tables, some of the samples were from hyperimmunized A/J mice that had been 
immunologically suppressed with respect to the CRI before immunization.  The SHYR-TE  JU,  ALFRED  GRAY,  AND  ALFRED  NISONOFF  547 
TABLE  I 
Effect of Haptens on the Reactions of Anti-~d Anttbodies 
Hapten 
Source of labeled h-  PABT  p -Arsanilate  p-Amlnobenzoate  gand* 
1.65  20  1.6  20  1 6  20 
J25I-label bound, % of controls§ 
HIS-5, pI 6.3 peak  45  8  107  54  113  130 
HIS-5, pI 6.9 peak  25  19  55  60  89  119 
HIS-13,  pI 6.9 peak  26  26  55  57  101  97 
HIS-7, pI 6 7 peak  9  2  12  12  112  84 
CRIII  57  52  85  78  90  109 
* The 12~I-labeled ligands (1.5-2 ng) were proteins m the peaks of specifically purified anhbodles 
designated by arrows in Figs. 1-3. The proteins were present in a buffered mixture containing 
1% BSA. The amount of antl-id antibody used was somewhat less than optimal  The pH of each 
mixture was 8.0. 
5 Concentration in millimoles per hter 
§ Expressed as percentage of the amount of hgand bound in the absence of hapten. 
II Specifically purified anti-Ar antibody from a nonsuppressed mouse, comprmmg approximately 
60% of the CRI. 
TABLE  II 
Displacement fro m A ntt-Idiotyp~c Antibody of the Major Peak (pI 6.7) of the 
Ant~-Ar Anttbody of the Suppressed A/J Mouse HIS-7 
Inhibitor (source of anti-Ar anhbody)  No  of Mice 
Nanograms Antl-Ar 
anltbody required for 
50% inhlbltion* 
Autologous (HIS-7, specifically  purffied) 
Nonsuppressed A/J mice 
A/J Mine suppressed for CRI 
Total no  of mice tested 
65  >10,000 
71  >25,000 
8  >75,000 
14  >10,000 
13  >25,000 
10  >75,000 
181 
* 1.5 ng of labeled hgand was used m the assay 
criterion for the presence of a  private  idiotype was the capacity to cause  more 
than  50% inhibition of binding in the radioimmunoassay.  Nearly all noninhibi- 
tory  sera  or  ascitic  fluids  caused  less  than  20%  inhibition.  The  same  set  of 
samples was tested as inhibitors in each system, with the exception that BALB/c 
sera were used only in the experiments  of Table V.  (The reason for testing the 
BALB/c  sera  in  this  system  will be  indicated  below.)  Thus,  the  experiments 
were designed to identify the presence of any of the four private idiotypes in the 
samples tested as inhibitors. 
Two of the private idiotypes studied (from mice HIS-7 and HIS-13) could not be 
detected in any of the mice investigated  (Tables II and III). In the case of HIS-7, 548  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
TABLE  III 
D~splacement of Labeled Anti-Ar Antzbod~es of A/J Mouse HIS-13 (pI 6.9 
fractmn) from their Anti-~d Antibodies 
Inhibitor (source of antl-Ar antibody)  No. of Mine 
Nanograms Antl-Ar 
antibody reqmred for 
50% inhibition* 
Autologous (HIS-13, specifically purified) 
Unfocused  85 
Focused (pI 6 9)  15 
Nonsuppressed A/J Mine 
A/J mice suppressed for CRI 
t 
5  >10,0005 
71  >25,000 
68  >75,000 
14  >10,000 
13  >25,000 
10  >75,000 
Total no  of mice tested  181 
* 2 ng of labeled hgand was used m the assay. 
$ These numbers are the same as those in Table II because the same 181 sera were 
used m the tests 
TABLE  IV 
D~splacement of Labeled Anti-Ar Antzbodles of A/J Mouse HIS-5 (pI 6.9 
fractton)  from their Anti-~d Ant~bodtes 
Inhibitor (source of antl-Ar antibody)  No  of Mice 
Nanograms Antl-Ar 
antibody reqmred for 
50% inhibition* 
Autologous (HIS-5, specifically purified) 
Unfocused  50 
Focused (pI 6 9)  15 
Focused (pI 6 3)  >135 
Nonsuppressed A/J mice 
A/J mice suppressed for CRI 
I 01  4 40o  40,000, 
>10,000 
>25,000 
>75,000 
t 
14  >10,000 
13  >25,000 
10  >75,000 
100,000 
Total no. of mice tested  181 
* 1.5 ng of labeled ligand was used in the assay 
8  ng of unlabeled autologous antibody caused 50%  inhibition of binding. This 
degree of inhibition  could not be achieved with 25/~1 of any of the other samples, 
containing  between 10,000 and 200,000 ng of anti-Ar antibody. A total of 181 A/J 
mice  were  tested,  of which  37  were  suppressed  with  respect  to  the  common, 
cross-reactive idiotype. Thus, less than  one molecule in 1,200 to less than  one SHYR-TE JU,  ALFRED GRAY, AND  ALFRED NISONOFF 
TABLE V 
Displacement  of Labeled Anti-Ar Antibodies of A/J Mouse HIS-5 (pI 6.3 
fraction) from  their Ant~-id Antibodies 
549 
Inhibitor (source of anti-Ar antibody)  No. of Mice 
Nanograms Anti-Ar anti- 
body required for 50% in- 
hibition* 
Autologous (HIS-5, specifically purified) 
Unfocused  37 
Focused (pI 6.3)  8 
Focused (pI 6.9)  >70 
Nonsuppressed A/J mice 
A/J mice suppressed for CRI 
BALB/c mice 
Total no. of A/J mice tested 
23  800, 1,400, 2,000 
18  3,000-10,000 
5  11,000-120,000 
45  >10,000 
49  >25,000 
4  >75,000 
I  3,000-10,000 
11,000-150,000 
13  >10,000 
109  >25,000 
>75,000 
1  i  >10,000 
>25,000 
>75,000 
181 
* 1.5 ng of labeled ligand was used m the assay 
molecule in 25,000 contained the HIS-7 idiotype; the actual concentrations may 
be much lower since 50% inhibition was never achieved. 
The same group of sera and ascitic fluids were tested as inhibitors in the HIS- 
13  system,  again  with  consistently negative  results.  In  this  case,  85  ng  of 
unfocused, autologous protein (specifically purified HIS-13 antibody) caused 50% 
inhibition of binding, whereas 15 ng of unlabeled protein with pI 6.9 (the same 
as that of the labeled ligand) caused 50% inhibition. Unlabeled antibody of the 
same mouse, HIS-13, but with pI 6.3,  was noninhibitory; only 150 ng was tested 
because of the necessity of isolating the material after focusing. 
The possibility was considered that the private idiotype might actually be 
present in some noninhibitory samples, but masked in some manner through 
interaction with another component. Therefore, 10 ng of unlabeled HIS-7 anti- 
Ar antibody was added to 25 ~1 of each of 20 randomly selected, noninhibitory 
ascitic fluids represented in Table II. The mixtures were then tested as inhibi- 
tors in the radioimmunoassay for the HIS-7 idiotype (pI 6.7).  In all cases more 
than 50% inhibition was observed (maximum, 74%). A similar experiment was 
done with 20 noninhibitory ascitic fluids with labeled HIS-5 (pI 6.9) as ligand. 
Addition of 50 ng of unlabeled, unfocused HIS-5 purified antibody caused more 
than 50% inhibition in each case. 
Table IV shows the results obtained with one of the two idiotypes isolated 550  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
from the anti-Ar antibodies of mouse HIS-5 (pI 6.9). In this case 3 of the 181 mice 
tested contained inhibitory protein.  However, the concentration in these three 
ascites  was  far  lower  than  that  in  protein  HIS-5,  since  4,400-100,000  ng  of 
antibody were required for 50% inhibition.  In this system, 50 ng of unlabeled, 
unfocused protein HIS-5 and 15 ng of focused protein having the same pI value 
as the  labeled ligand  were required  for 50%  inhibition  of binding.  Unlabeled 
antibody of the autologous mouse (HIS-5), but with a  different pI value (6.3), 
was noninhibitory at the highest concentration tested (135 ng caused 8% inhibi- 
tion of binding). 
The idiotype of the anti-Ar antibodies of the same mouse, HIS-5, but with pI 
6.3, differed markedly from the other three idiotypes tested, in that a  substan- 
tial  number  of the  samples  tested  were  inhibitory  (Table  V);  however,  the 
concentration of the idiotype was always much lower than that in mouse HIS-5. 
Of  181  A/J  mice  tested,  51  contained  enough  of the  idiotype  to  cause  50% 
inhibition.  Owing  to the  large  amounts  of protein  required,  the  data  do not 
establish whether the idiotypes are identical or cross-reactive (16), or how many 
idiotypes comprise the inhibitory protein. 
Supporting the possibility that the observed inhibition reflects an identical or 
cross-reactive idiotype was the absence of inhibitory capacity in 26 individual 
BALB/c sera containing 0.32-4.4 mg/ml anti-Ar antibodies; 25 ~1 was tested. In 
addition,  21 individual A/J sera containing high titers of antibodies to a  conju- 
gate of KLH with p-azophenyltrimethylammonium  groups were noninhibitory. 
The presence of high  concentrations  of antibodies to both the protein and the 
hapten in each sample was shown by Ouchterlony analysis. 
These results suggest but do not establish that the inhibition by certain ascitic 
fluids in the HIS-5 (pI 6.3) system is due to the presence of anti-Ar antibodies. To 
test this  possibility,  ascitic fluids from 10 mice with inhibitory  capacity were 
adsorbed with Sepharose-4B conjugated to bovine IgG (BGG)-Ar. As a  control, 
similar  adsorptions  were  carried  out  with  A/J  IgG  in  place  of BGG-Ar;  the 
amounts used are specified in Table VI.  Mixtures were allowed to stand with 
frequent  agitation  at  room  temperature  for  1 h,  then  overnight  at  4°C.  The 
inhibitory capacity was decreased in all of the supernates of fluids adsorbed with 
the BGG-Ar conjugate; in 7 of the 10 mice the removal was essentially complete 
(Table VI).  After adsorption with the BGG-Ar conjugate,  all samples lost the 
ability  to  form  a  precipitin  band  with  BGG-Ar  in  the  Ouchterlony  test but 
retained their precipitating activity against KLH. 
Discussion 
The experiments  were designed to determine the frequency of occurrence of 
~private" idiotypes of anti-Ar antibodies that arise on immunization with KLH- 
Ar of mice that are immunologically suppressed with respect to the intrastrain 
CRI associated with these antibodies in normal A/J mice. For use as ligands in 
the radioimmunoassay anti-Ar antibodies were obtained from four single peaks 
after isoelectric focusing of the specifically purified antibodies from three ran- 
domly selected mice.  Over 90%  of each ligand  was precipitable by autologous 
anti-id  antibodies,  using  the  double-antibody procedure.  These proteins  refo- 
cused as single peaks with little or no change in pI, and it was shown that the SHYR-TE  JU,  ALFRED  GRAY,  AND  ALFRED  NISONOFF 
TABLE  VI 
Assoczatmn Between the Capacity to Inhibit Antibodies to the 
HIS-5 (pI 6.3) Idiotype and the Presence of Anti-Ar Antibodies* 
Source of inhibitor, A/J 
mouse no. 
Protein Conjugated to Sepharose-4B 
A/J IgG  BGG-Ar 
125I-ligand bound,  % of Control* 
19  53 (1)  105 (10) 
10  40 (2)  104 (6) 
16  19 (1)  99 (7) 
48  19 (1)  96 (15) 
39  32 (4)  96 (4) 
44  22 (0)  92 (12) 
24  59 (10)  88 (6) 
49  53 (1)  70 (1) 
37  35 (6)  56 (4) 
22  30 (3)  51 (1) 
* 200 ~1 ofascltic fluid from each of 10 randomly chosen mice expressing 
the  HIS-5  (pI  6.3)  idiotype  were  adsorbed  with  300  /~l  of packed 
Sepharose-4B conjugated with bovine IgG-Ar or normal A/J IgG (2 
mg/ml of packed beads). 25 pl of the supernate was tested as Inhibitor 
m  the radioimmunoassay for the idlotype. 
$ Mean values of duphcate tests, with average deviations in parenthe- 
ses. 
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iodination procedure did not significantly affect the pI value. The usefulness of 
isoelectric focusing, to enhance detectability of the idiotype in other mice, was 
supported by the identification of two unrelated idiotypes (pI 6.3 and 6.9),2 in the 
anti-Ar  antibodies  of mouse  HIS-5,  and  by  the  heterogeneity  of all  of the 
isoelectric-focusing patterns. 
Small amounts of labeled ligand (1-2 ng) were used in the radioimmunoassays 
to maximize the sensitivity of detection of the idiotype in the unlabeled prepara- 
tions tested as inhibitors.  A  total of four labeled ligands were used; two from 
proteins HIS-7 and HIS-13 and the two unrelated idiotypes from protein HIS-5. 
All of the anti-id antisera were inhibited,  to varying degrees, by free haptens 
(Table I)2 
Using the criterion of 50% inhibition of binding of the labeled ligand for the 
presence of the corresponding idiotype, two of the four private idiotypes studied 
(HIS-7 and HIS-13) could not be detected in any immunized mouse other than 
the donor. The amounts of anti-Ar antibodies tested varied from 10 to 200/~g. In 
2  These 2 idiotypes  arlse  Independently, as shown by the fact  that the ldiotype  associated  with 
anti-Ar antibody ofpl 6.3  was detected  quite  frequently m other immunized A/J mice, whereas the 
other idiotype  was not. 
A  term sometimes used m  dlscussing those idiotypes that are not directly  affected  by the 
presence of  a small hapten, i  e ,  are not ligand modifiable,  is  "framework idiotype  "The use of  this 
term would seem to reqmre further  justificatlon  since  the hypervariable region of  an antibody is 
much larger than a typical  hapten. Even those anti-id  antibodies which are not inhibited  by the 
presence of  hapten might be directed  entlrely  or in  part to  hypervariable segments. Also, haptens 
may fail  to  inhiblt  binding at concentratlons high enough to  saturate their  binding sites,  because 
of  low affinity  m  comparison to the anti-ld  antibodies with whlch they are competing (17) 552  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
contrast,  8  and  15  ng of the two unlabeled ligands caused 50%  inhibition of 
binding, respectively. The private idiotypes thus represented less than 1 part in 
1,250 to less than 1 part in 25,000 of the anti-Ar antibodies of the other 181 mice 
tested. This group included 37 mice that had been suppressed with respect to the 
CRI before immunization. That the failure to detect the idiotype was not due to 
some factor that masked the idiotype was shown by adding very small amounts 
of autologous idiotypes to noninhibitory ascitic fluids; in all cases strong inhibi- 
tion was observed. 
There is obviously a striking contrast between the CRI which appears in the 
anti-Ar antibodies of every normal A/J mouse, and the private idiotypes which 
occur at very low frequency or are not detectable in other mice. It seems possible 
that the CRI represents the product of a germ line gene or genes, or arises from 
germ line genes by a very small number of mutations that take place in every 
mouse (1). The infrequency of occurrence of the two private idiotypes appears 
consistent with the hypothesis that they are generated by a substantial number 
of somatic mutations, so that their probability of occurrence in any individual 
mouse is exceedingly small. The very low frequency seems to us to suggest a 
random, rather than a programmed (18-20) somatic process for the generation of 
diversity. The results do not formally prove this, since one might postulate that 
an extremely large repertoire of anti-Ar antibodies is produced in a sequential 
manner, with only a few idiotypes capable of expression at any given moment. 
Our sample of inhibitors, although large, might have been inadequate. It should 
be stressed, however, that each of the hyperimmunized mice tested undoubtedly 
produced  many  clones  of anti-Ar  antibodies  (judging from  those  that  were 
studied by isoelectric focusing) and that only a  few nanograms per milliliter 
would have been detected, as evidenced by experiments in which small amounts 
of the  unlabeled  idiotype  were  added  to  noninhibitory antibody-containing 
fluids. Also,  the data on which the hypothesis of programmed mutation are 
based do not appear conclusive.  4 
So far we have discussed the two private idiotypes that were not detectable in 
other mice. A third private idiotype, associated with protein HIS-5 (pI 6.9) was 
present in 3 of 181 immunized mice, but at very low concentrations (Table IV). 
The fourth idiotype (protein HIS-5, pI 6.3) was detected by our assay in 28% of 
A/J mice immunized with KLH-Ar, in all cases at a low concentration in com- 
parison to that in mouse HIS-5.  When present, it comprised from 1 part in 100 
to 1 part in 25,000 of  the anti-Ar population. We do not know whether the inhibi- 
tory material is an identical idiotype or a cross-reactive idiotype (16).  5 However, 
its concentration was reduced by adsorption with a  BGG-Ar-Sepharose conju- 
gate, and it was completely removed in 7 of the 10 ascitic fluids tested. Also, 
the anti-Ar antibodies of  26 BALB/c mice, and antibodies to an unrelated hapten 
4 For example, the appearance of the TEPC 15 idlotype on day 6 might reflect the activation of a 
germ line gene at this time rather than a  systematic timed series of mutations (21). In other 
relevant investigations (19,  20),  idlotypes or spectrotypes were not defined, although evidence 
supporting a programmed appearance of antibody speclficities was presented. 
5 In this publication it was also shown that idiotypes characteristic of certain human Bence 
Jones proteins or myeloma proteins are present in a concentration below 1 part in 106, or i part m 
10 T, respectively, in pooled normal human ~/-globuhn. SHYR-TE  JU,  ALFRED  GRAY,  AND  ALFRED  NISONOFF  553 
on the same carrier from 21 A/J mice were not inhibitory. The data thus suggest 
that the inhibitor, when present, is associated with an identical or cross-reactive 
idiotype. The relatively frequent appearance of this idiotype would be accommo- 
dated within our hypothesis by the assumption that it arises through a smaller 
number of mutations than the other three idiotypes investigated, with a conse- 
quently higher probability of appearance.  Even this idiotype, however, never 
represented a  major proportion of the anti-Ar response of a  mouse, and thus 
contrasts markedly with the CRI characteristic of nonsuppressed A/J mice. 
The fact that maps of VH genes can be constructed (22) does not disprove the 
possibility of somatic mutations, but rather suggests that those genes used in 
the construction of the maps are germ line genes or closely related to germ line 
genes through a small number of mutations which occur in every mouse. Only 
those genes whose products are found in most or all mice of a strain can be used 
for mapping, and our data on the anti-Ar antibodies in the A/J strain would 
suggest that most immunoglobulin gene products could not be applied to map 
construction,  owing  to  their  restricted  occurrence  within the  members  of a 
strain. 
Experiments have also been done in which mice of seven strains other than 
A/J were immunized with KLH-Ar (23). A  total of 16  anti-id antisera  were 
prepared against anti-Ar antibodies of individual mice and tested against the 
anti-Ar antibodies of other mice of the same strain. Strong intrastrain idiotypic 
cross-reactions among the anti-Ar antibodies were not observed in any of these 
strains, although a weak set of intrastrain cross-reactions was noted in BALB/c 
mice with one  of three anti-id antisera tested.  The other strains used  were 
AKR/J, C57Br/CdJ, LP/J, RF/J, SM/J, and SWR/J. 
The present data support those of other investigators (24-26),  in indicating 
that the repertoire of anti-hapten or anti-protein antibodies in an individual 
strain is very large. In our experiments a few major spectrotypes and a number 
of minor spectrotypes of anti-Ar antibodies typically appeared upon immuniza- 
tion of an individual mouse. 
A finding that is somewhat difficult to reconcile with the data obtained with 
inbred mice is that of DuPasquier and Wabl (27), who worked with genetically 
identical  (isogenetic)  frogs.  Such  animals produce  antibodies to the  dinitro- 
phenyl hapten group or to sheep erythrocytes that exhibit virtually identical 
isoelectric-focusing patterns.  Possible explanations include the following: (a) 
Inbred mice do not all have identical sets of germ line V genes, although regions 
of identity must exist to account for intrastrain CRI;  (b)  somatic mutational 
processes might be of much greater significance in mammals than in amphibia; 
(c) somatic mutations are programmed by genes that are identical in isogenetic 
frogs but which may exhibit variability in inbred mice; (d) all immunoglobulins 
are the products of germ line genes, with mice having the greater repertoire. 
Recent data on mRNA-DNA hybridization, suggesting the existence of a limited 
number of germ-line V-region genes  in mice  (e.g.,  28-30)  argue against the 
latter possibility. Our data do not bear directly on the validity of the "gene- 
insertion" model (31, 32) to account for the presence of hypervariable regions, 
except to suggest that, if it is correct, the number of such genes must be very 
large. 554  FREQUENCY  OF  OCCURRENCE  OF  PRIVATE  IDIOTYPES 
Summary 
Inoculation of rabbit anti-idiotypic (anti-id) antibodies suppresses the subse- 
quent appearance of a cross-reactive idiotype (CRI) associated with the anti-p- 
azophenylarsonate  (anti-Ar)  antibodies  of A/J  mice.  Such  suppressed  mice 
produce normal concentrations of anti-Ar antibodies which lack the CRI, but 
against which anti-id antisera can be prepared.  The anti-Ar antibodies of an 
individual, suppressed  mouse do  not in general share  idiotype with anti-Ar 
antibodies of other A/J mice, either suppressed or nonsuppressed. The present 
experiments  were  undertaken to  quantitate several  "private idiotypes" in  a 
large number of hyperimmunized A/J mice. Anti-Ar antibodies of three mice, 
suppressed  for  the  CRI,  were  labeled  with  125I and  subjected  to  isoelectric 
focusing. Four single peaks, that were over 90% reactive with autologous anti- 
id, were randomly selected for use as ligands in a radioimmunoassay, and ascitic 
fluids containing anti-Ar antibodies from 181 A/J mice were tested as inhibitors. 
Two of the four idiotypes could not be detected in any mouse other than the 
donor. The concentration of  the idiotype was less than 1 part in 1,250 to less than 
1 part in 25,000 of the anti-Ar antibody population; these are minimum values. 
A third idiotype was detected in 3 of the 181 mice, but at very low concentra- 
tions.  The  fourth idiotype was  present  in  28%  of the  mice,  again  at  a  low 
concentration. The data support the existence of a very large repertoire of anti- 
Ar antibodies in the A/J strain and are consistent with a  process of random 
somatic mutation for generating diversity in hypervariable regions. It is pro- 
posed that the cross-reactive idiotype may be controlled by a germ line gene or a 
gene related to a germ line gene through a small number of somatic mutations; 
and that the idiotypes that were not detectable in other mice were the products 
of genes that had undergone extensive mutations, with a  low probability of 
recurrence in other mice. 
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